| Berbamine |
Cytokine level estimtion |
ELISA |
50.00 mg/kg |
Splenocytes |
Mus musculus |
c57BL/6 |
|
|
| Berbamine |
Cytokine level estimtion |
ELISA |
50.00 mg/kg |
Splenocytes |
Mus musculus |
c57BL/6 |
|
|
| Berbamine |
Cytokine level estimtion |
ELISA |
50.00 mg/kg |
Splenocytes |
Mus musculus |
c57BL/6 |
|
|
| Berbamine |
Cytokine level estimtion |
ELISA |
50.00 mg/kg |
Splenocytes |
Mus musculus |
c57BL/6 |
|
|
| Berbamine |
Cytokine level estimtion |
ELISA |
50.00 mg/kg |
Splenocytes |
Mus musculus |
c57BL/6 |
|
|
| Berbamine |
Cytokine level estimtion |
ELISA |
50.00 mg/kg |
Splenocytes |
Mus musculus |
c57BL/6 |
|
|
| Berbamine |
Cytokine level estimtion |
ELISA |
50.00 mg/kg |
Splenocytes |
Mus musculus |
c57BL/6 |
|
|
| Berbamine |
Cytokine level estimtion |
ELISA |
50.00 mg/kg |
Splenocytes |
Mus musculus |
c57BL/6 |
|
|
| Berbamine |
Cytokine level estimtion |
ELISA |
50.00 mg/kg |
Splenocytes |
Mus musculus |
c57BL/6 |
|
|
| BBMD3 (berbamine derivative) |
Cell viability |
ELISA |
1.00 µM |
A2058 |
Homo sapiens |
|
|
|
| BBMD3 (berbamine derivative) |
Cell viability |
ELISA |
2.00 µM |
A2058 |
Homo sapiens |
|
|
|
| BBMD3 (berbamine derivative) |
Cell viability |
ELISA |
3.00 µM |
A2058 |
Homo sapiens |
|
|
|
| BBMD3 (berbamine derivative) |
Cell viability |
ELISA |
4.00 µM |
A2058 |
Homo sapiens |
|
|
|
| BBMD3 (berbamine derivative) |
Cell viability |
ELISA |
5.00 µM |
A2058 |
Homo sapiens |
|
|
|
| BBMD3 (berbamine derivative) |
Cell viability |
ELISA |
10.00 µM |
A2058 |
Homo sapiens |
|
|
|
| BBMD3 (berbamine derivative) |
Cell viability |
ELISA |
1.00 µM |
A375 |
Homo sapiens |
|
|
|
| BBMD3 (berbamine derivative) |
Cell viability |
ELISA |
2.00 µM |
A375 |
Homo sapiens |
|
|
|
| BBMD3 (berbamine derivative) |
Cell viability |
ELISA |
3.00 µM |
A375 |
Homo sapiens |
|
|
|
| BBMD3 (berbamine derivative) |
Cell viability |
ELISA |
4.00 µM |
A375 |
Homo sapiens |
|
|
|
| BBMD3 (berbamine derivative) |
Cell viability |
ELISA |
5.00 µM |
A375 |
Homo sapiens |
|
|
|
| BBMD3 (berbamine derivative) |
Cell viability |
ELISA |
10.00 µM |
A375 |
Homo sapiens |
|
|
|
| BBMD3 (berbamine derivative) |
Cell viability |
ELISA |
1.00 µM |
G361 |
Homo sapiens |
|
|
|
| BBMD3 (berbamine derivative) |
Cell viability |
ELISA |
2.00 µM |
G361 |
Homo sapiens |
|
|
|
| BBMD3 (berbamine derivative) |
Cell viability |
ELISA |
3.00 µM |
G361 |
Homo sapiens |
|
|
|
| BBMD3 (berbamine derivative) |
Cell viability |
ELISA |
4.00 µM |
G361 |
Homo sapiens |
|
|
|
| BBMD3 (berbamine derivative) |
Cell viability |
ELISA |
5.00 µM |
G361 |
Homo sapiens |
|
|
|
| BBMD3 (berbamine derivative) |
Cell viability |
ELISA |
10.00 µM |
G361 |
Homo sapiens |
|
|
|
| BBMD3 (berbamine derivative) |
Cell viability |
ELISA |
1.00 µM |
SK-MEL-28 |
Homo sapiens |
|
|
|
| BBMD3 (berbamine derivative) |
Cell viability |
ELISA |
2.00 µM |
SK-MEL-28 |
Homo sapiens |
|
|
|
| BBMD3 (berbamine derivative) |
Cell viability |
ELISA |
3.00 µM |
SK-MEL-28 |
Homo sapiens |
|
|
|
| BBMD3 (berbamine derivative) |
Cell viability |
ELISA |
4.00 µM |
SK-MEL-28 |
Homo sapiens |
|
|
|
| BBMD3 (berbamine derivative) |
Cell viability |
ELISA |
5.00 µM |
SK-MEL-28 |
Homo sapiens |
|
|
|
| BBMD3 (berbamine derivative) |
Cell viability |
ELISA |
10.00 µM |
SK-MEL-28 |
Homo sapiens |
|
|
|
| BBMD3 (berbamine derivative) |
Cell viability |
ELISA |
1.00 µM |
SK-MEL-5 |
Homo sapiens |
|
|
|
| BBMD3 (berbamine derivative) |
Cell viability |
ELISA |
2.00 µM |
SK-MEL-5 |
Homo sapiens |
|
|
|
| BBMD3 (berbamine derivative) |
Cell viability |
ELISA |
3.00 µM |
SK-MEL-5 |
Homo sapiens |
|
|
|
| BBMD3 (berbamine derivative) |
Cell viability |
ELISA |
4.00 µM |
SK-MEL-5 |
Homo sapiens |
|
|
|
| BBMD3 (berbamine derivative) |
Cell viability |
ELISA |
5.00 µM |
SK-MEL-5 |
Homo sapiens |
|
|
|
| BBMD3 (berbamine derivative) |
Cell viability |
ELISA |
10.00 µM |
SK-MEL-5 |
Homo sapiens |
|
|
|
